Focus

Focus "Rectal cancer": securing excellence beyond the scalpel

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies in Switzerland (1). The lifetime-risk of developing CRC is around 4-5% in women and men (2). Early detection of pre-cancerous lesions or early-stage CRC through an effective and high-quality screening program and regular surveillance post-treatment are essential.

For nearly two decades, the standard treatment for locally advanced rectal cancer (LARC) involved chemoradiation therapy (CRT) followed by surgery and optional additional chemotherapy. 

If there were no hospitals in Switzerland yet and we could plan a hospital system from scratch, what would it look like? 

The story behind intratumoral budding in rectal cancer

Clinical Implementation, Pitfalls and Risks

Présentation d’un cas clinique sur la fenestration laser in situ de la crosse aortique lors d’un congrès au Japonbitte

Quality control in vascular surgery is essential. Is running a registry worth the effort? This article shows the strength and the limits of the Swiss vascular registry "Swissvasc" and describes possible developments for improved national data quality by even reducing the administrative effort.

Standardized Dose Reporting, Education and Cultivation of an “Ultra-Low Dose Mindset” for Dose Reduction in Endovascular Surgery

The integration of smart glasses technology into surgical practice marks a significant advancement in modern medicine.

The specialty of vascular surgery has evolved dramatically in the last three decades.